FDA Grants Fast Track Approval Of New Leukemia Treatment
Older patients with acute myeloid leukemia (AML) often aren’t healthy enough to receive intensive chemotherapy, and gentler treatments aren’t very effective in treating this aggressive blood cancer. But a new option – a combination of a standard drug and the novel agent venetoclax – has been granted accelerated approval by the Food and Drug Administration for such patients after a large, multicenter phase 1 clinical trial showed the combination had “promising efficacy” and was well tolerated in older AML patients.
Login to read the full story or Subscribe now!
Other Recent Stories
Data thieves don’t take a break during the holidays. In fact, the IRS warns taxpayers that the agency is seeing a large increase in bogus email schemes that seek to steal money or tax data.
Of the 165,000 men in the U.S. expected to be diagnosed with prostate cancer this year, according to the American Cancer Society, about half will have low-risk disease. Many of those patients—about half, according to a 2016 study published in JAMA Oncology—will opt for active surveillance rather than surgery.
Workers and their families are spending a bigger share of their income on health care than ever before – and that’s especially true in the South, according to a new report from the nonpartisan Commonwealth Fund. The authors of the report found that average employee premium contributions for single and family plans amounted to nearly 7% of U.S. median income in 2017, up from 5% in 2008.
A newly released national poll finds that older adults and people with disabilities are facing significant transportation-related challenges once they no longer drive. They feel there is a lack of accessible and reliable transportation alternatives, which prevents them from doing the things they need and want to do and leaves them feeling frustrated, isolated and trapped.
This is among the first known studies to examine whether fluctuations in business cycles (economic expansions and recessions) affects quality of nursing home care, nursing staff levels, and turnover/retention of staff. The study examines more than a decade of records.
John A. Hartford Foundation has awarded five new grants totaling more than $5.2 million to implement and disseminate evidence-based approaches to better care for older adults.
Although the holidays can be especially stressful for families living with Alzheimer’s, maintaining or adapting family rituals and traditions can help all family members feel connected. Follow these tips to help you have an enjoyable holiday season...
Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive “tracer” molecules that bind to and “light up” tau tangles, a protein associated with a number of neurodegenerative diseases including Alzheimer’s disease and other related dementias.
Quick tests used in primary care settings to identify whether people are likely to have dementia may often be wrong, according to a newly published study. The tests, called brief cognitive assessments, evaluate thinking and memory skills. They help doctors decide who may benefit from a full diagnostic assessment for dementia.
The Senate Aging Committee has been alerted of appalling stories from Americans across the country regarding abusive guardianships that take advantage of vulnerable individuals.